×
About 285 results

ALLMedicine™ Anaplastic Oligodendroglioma Center

Research & Reviews  98 results

A single institution retrospective analysis on survival based on treatment paradigms fo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279971
Journal of Neuro-oncology; Bush NAO, Young JS et. al.

Jun 15th, 2021 - Anaplastic oligodendrogliomas are high-grade gliomas defined molecularly by 1p19q co-deletion. There is no curative therapy, and standard of care includes surgical resection followed by radiation and chemotherapy. However, the benefit of up-front ...

TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas...
https://doi.org/10.1002/onco.13765
The Oncologist; Tabouret E, Fabbro M et. al.

Mar 31st, 2021 - Treatment with temozolomide and BCNU was associated with substantial response and survival rates for patients with unresectable anaplastic glioma, suggesting potential therapeutic alternative for these patients. The optimal treatment for unresecta...

Prolonged benefit to pembrolizumab in anaplastic oligodendroglioma patient with mismatc...
https://doi.org/10.1097/CAD.0000000000001011
Anti-cancer Drugs; Padovan M, Caccese M et. al.

Jan 5th, 2021 - High-grade gliomas, including anaplastic oligodendroglioma, represent the most common malignant neoplasms of the central nervous system in the adult. The standard treatment of anaplastic oligodendroglioma consists of maximum surgical resection, ra...

Treatment of patients with glioma during the COVID-19 pandemic: what we learned and wha...
https://doi.org/10.3171/2020.9.FOCUS20704
Neurosurgical Focus; Pessina F, Navarria P et. al.

Dec 2nd, 2020 - Coronavirus disease 2019 (COVID-19) has changed the way in which cancer is treated. Patients with high-grade glioma (HGG) are believed to be in a vulnerable category. The aim of this study was to describe the experience of a hub cancer center and ...

Anaplastic Oligodendroglioma - Is Adjuvant Radiotherapy Mandatory following Maximal Sur...
https://doi.org/10.1016/j.clineuro.2020.106303
Clinical Neurology and Neurosurgery; Profyris C, Chen E et. al.

Oct 29th, 2020 - Current anaplastic oligodendroglioma (AO) management strategies involve surgical resection followed by adjuvant radiotherapy and/or chemotherapy. We investigated a subset of patients at our institution with AO, who, based on their treatment prefer...

see more →

Guidelines  1 results

Central nervous system cancers.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124889
Journal of the National Comprehensive Cancer Network : JN... Nabors LB, Ammirati M et. al.

Sep 14th, 2013 - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemothera...

see more →

Clinicaltrials.gov  12 results

Topotecan in Treating Patients With Recurrent Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT00003372

Apr 8th, 2020 - OBJECTIVES: I. Determine the efficacy of topotecan in patients with recurrent anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma. II. Determine the qualitative and quantitative toxicity of topotecan in this patient population on thi...

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
https://clinicaltrials.gov/ct2/show/NCT00588523

Oct 30th, 2019 - The purpose of this study is to see how effective treatment of high doses of chemotherapy is for your tumor. We will also be looking at the side effects and risks of this treatment. You will receive very high doses of chemotherapy. High doses of c...

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
https://clinicaltrials.gov/ct2/show/NCT00400816

Sep 18th, 2018 - OBJECTIVES: Determine progression-free survival of patients with newly diagnosed anaplastic oligodendroglioma (AO) or mixed oligoastrocytoma (MOA) treated with temozolomide. Determine the response rate in these patients. Assess the quality of life...

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
https://clinicaltrials.gov/ct2/show/NCT00002569

Jun 18th, 2018 - OBJECTIVES: Compare the overall survival and time to tumor progression in patients with unifocal or multifocal, supratentorial, pure or mixed anaplastic oligodendroglioma treated with radiotherapy with or without procarbazine, lomustine, and vincr...

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT00303849

May 3rd, 2018 - PRIMARY OBJECTIVES: I. To evaluate toxicity and estimate the maximum tolerated dose (MTD) of melphalan (intra-arterially [i.a.]) administered in conjunction with carboplatin (i.a.) and etoposide phosphate (intravenously [i.v.]) undergoing BBBD, in...

see more →

News  3 results

Plenary Sunday at ASCO
https://www.onclive.com/publications/obtn/2012/july-2012/plenary-sunday-at-asco

Jul 26th, 2012 - Andrew L. Pecora, MD Editor-in-Chief Oncology & Biotech News Chief Innovations Officer, Professor, and Vice President of Cancer Services John Theurer Cancer Center at Hackensack University Medical Center I am sure any of us can think of many other...

Thunderclap Headache Associated With a Nonhemorrhagic Anaplastic Oligodendroglioma
https://www.medscape.com/viewarticle/559493

Case Report A thunderclap headache is a severe headache with sudden onset similar to a clap of thunder, with a maximum intensity within 1 minute. The primary types (thunderclap, cough, exertional, and sexual) can recur intermittently and are gener...

Thunderclap Headache Associated With a Nonhemorrhagic Anaplastic Oligodendroglioma
https://www.medscape.com/viewarticle/559493_2

Discussion Although Day and Raskin[1] initially coined the term thunderclap headache to refer to the headache associated with an unruptured aneurysm, the most common secondary cause is subarachnoid hemorrhage. Other secondary causes include cerebr...

see more →